Matches in Wikidata for { <http://www.wikidata.org/entity/Q81916869> ?p ?o ?g. }
- Q81916869 description "2008 nî lūn-bûn" @default.
- Q81916869 description "2008年の論文" @default.
- Q81916869 description "2008年学术文章" @default.
- Q81916869 description "2008年学术文章" @default.
- Q81916869 description "2008年学术文章" @default.
- Q81916869 description "2008年学术文章" @default.
- Q81916869 description "2008年学术文章" @default.
- Q81916869 description "2008年学术文章" @default.
- Q81916869 description "2008年學術文章" @default.
- Q81916869 description "2008年學術文章" @default.
- Q81916869 description "2008年學術文章" @default.
- Q81916869 description "2008年學術文章" @default.
- Q81916869 description "2008年學術文章" @default.
- Q81916869 description "2008년 논문" @default.
- Q81916869 description "article científic" @default.
- Q81916869 description "article scientific" @default.
- Q81916869 description "article scientifique" @default.
- Q81916869 description "articol științific" @default.
- Q81916869 description "articolo scientifico" @default.
- Q81916869 description "artigo científico" @default.
- Q81916869 description "artigo científico" @default.
- Q81916869 description "artigo científico" @default.
- Q81916869 description "artikel ilmiah" @default.
- Q81916869 description "artikull shkencor" @default.
- Q81916869 description "artikulong pang-agham" @default.
- Q81916869 description "artykuł naukowy" @default.
- Q81916869 description "artículo científico publicado en 2008" @default.
- Q81916869 description "artículu científicu" @default.
- Q81916869 description "bilimsel makale" @default.
- Q81916869 description "bài báo khoa học" @default.
- Q81916869 description "naučni članak" @default.
- Q81916869 description "scienca artikolo" @default.
- Q81916869 description "scientific article published in September 2008" @default.
- Q81916869 description "scientific article published in September 2008" @default.
- Q81916869 description "scientific article published on 01 September 2008" @default.
- Q81916869 description "teaduslik artikkel" @default.
- Q81916869 description "tieteellinen artikkeli" @default.
- Q81916869 description "tudományos cikk" @default.
- Q81916869 description "vedecký článok" @default.
- Q81916869 description "vetenskaplig artikel" @default.
- Q81916869 description "videnskabelig artikel udgivet september 2008" @default.
- Q81916869 description "vitenskapelig artikkel" @default.
- Q81916869 description "vitskapeleg artikkel" @default.
- Q81916869 description "vědecký článek" @default.
- Q81916869 description "wetenschappelijk artikel" @default.
- Q81916869 description "wissenschaftlicher Artikel" @default.
- Q81916869 description "επιστημονικό άρθρο" @default.
- Q81916869 description "мақолаи илмӣ" @default.
- Q81916869 description "наукова стаття, опублікована у вересні 2008" @default.
- Q81916869 description "научна статия" @default.
- Q81916869 description "научная статья" @default.
- Q81916869 description "научни чланак" @default.
- Q81916869 description "научни чланак" @default.
- Q81916869 description "מאמר מדעי" @default.
- Q81916869 description "مقالة علمية نشرت في سبتمبر 2008" @default.
- Q81916869 description "সেপ্টেম্বর ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q81916869 description "บทความทางวิทยาศาสตร์" @default.
- Q81916869 description "სამეცნიერო სტატია" @default.
- Q81916869 name "Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma" @default.
- Q81916869 name "Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma" @default.
- Q81916869 type Item @default.
- Q81916869 label "Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma" @default.
- Q81916869 label "Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma" @default.
- Q81916869 prefLabel "Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma" @default.
- Q81916869 prefLabel "Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma" @default.
- Q81916869 P1433 Q81916869-358BB358-A6FF-4B4F-9311-F72132CE6686 @default.
- Q81916869 P1476 Q81916869-C23DA4DB-ECC3-4C43-B46A-601A0313A8F3 @default.
- Q81916869 P2093 Q81916869-178A0600-DE72-46E8-9B39-FA7E92888D2C @default.
- Q81916869 P2093 Q81916869-25B27970-6033-4A57-A01C-D164A0EAF652 @default.
- Q81916869 P2093 Q81916869-2AB2090E-C6D7-44E9-8CF7-0D70080F8B87 @default.
- Q81916869 P2093 Q81916869-A04D8657-D592-4B08-9716-6961D892AAF3 @default.
- Q81916869 P2093 Q81916869-ABC53917-AD3B-4A58-A261-F0F004773A52 @default.
- Q81916869 P2093 Q81916869-AF01E813-FB45-4757-A1D7-862727030A90 @default.
- Q81916869 P2093 Q81916869-B72D7783-1D14-4B4A-804E-18447CE7E4E0 @default.
- Q81916869 P2093 Q81916869-BF739736-18ED-4908-A56E-C9B3368FBEC6 @default.
- Q81916869 P2093 Q81916869-CA1B541E-0290-4345-A59A-F4DA2B88B276 @default.
- Q81916869 P2093 Q81916869-D2070C07-44F7-48CD-9C45-69C2F2FBDF94 @default.
- Q81916869 P2093 Q81916869-F7083DBC-4D89-4424-A303-5DC4A2B7868E @default.
- Q81916869 P304 Q81916869-DDB72E99-55FC-460D-9150-CFBD2687178D @default.
- Q81916869 P31 Q81916869-06347A3D-A5DB-40CF-B4D4-8F7F669ED30F @default.
- Q81916869 P356 Q81916869-2015A692-BA8D-406F-8BA6-D715D5C311ED @default.
- Q81916869 P407 Q81916869-4680A5F7-D556-4B39-8185-28FC687EF8FA @default.
- Q81916869 P433 Q81916869-CEC65677-1EB9-4001-AE49-0A16FD69ADE6 @default.
- Q81916869 P478 Q81916869-6A516DB3-A8AB-4862-91D2-4C3DE67B8130 @default.
- Q81916869 P50 Q81916869-5A6432AB-906C-4A31-97E6-3E3E6DB7911D @default.
- Q81916869 P50 Q81916869-e4b59908-481a-b711-fea7-51ae84026649 @default.
- Q81916869 P577 Q81916869-63FD8F2C-9F48-465F-B9FF-FE983845FF33 @default.
- Q81916869 P698 Q81916869-B941795F-0607-45BB-B83F-0600F788BE3B @default.
- Q81916869 P921 Q81916869-479CA304-AD31-49BD-9991-055AC14FB02C @default.
- Q81916869 P921 Q81916869-8BDD30D1-F4A6-449A-A944-4F743BED4C20 @default.
- Q81916869 P921 Q81916869-BE3E3884-8DE1-410F-8809-8CA7B01C818E @default.
- Q81916869 P356 J.1365-2141.2008.07353.X @default.
- Q81916869 P698 18764869 @default.
- Q81916869 P1433 Q4970200 @default.
- Q81916869 P1476 "Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma" @default.
- Q81916869 P2093 "Adriana Lopez" @default.
- Q81916869 P2093 "Alma Rodriguez" @default.
- Q81916869 P2093 "Anas Younes" @default.
- Q81916869 P2093 "Barbara Pro" @default.
- Q81916869 P2093 "Brian Leber" @default.